Showing results (1-10 of 1,396) with videos related to
Sort By:
Pageof 140
Pharmacology Research & Perspectives|November 23, 2022
Effects of a ritonavir-containing regimen on the pharmacokinetics of sirolimus or everolimus in healthy adult subjectsJiuhong Zha, Qi Jiang, Betty B Yao, et al.Pharmacology Research & Perspectives|October 13, 2020
Serious cardiovascular adverse events with fluoroquinolones versus other antibiotics: A self-controlled case series analysisSherrie L Aspinall, Nathan P Sylvain, Xinhua Zhao, et al.Pharmacology Research & Perspectives|January 21, 2020
Immunological characterization of HM5023507, an orally active PI3Kδ/γ inhibitorYu Cai, Jun Yu, Ping Ren, et al.Pharmacology Research & Perspectives|September 15, 2020
Pharmacological hypothesis: TPC2 antagonist tetrandrine as a potential therapeutic agent for COVID-19Paula M Heister, Robin N PostonPharmacology Research & Perspectives|June 15, 2021
Carrageenan nasal spray may double the rate of recovery from coronavirus and influenza virus infections: Re-analysis of randomized trial dataHarri Hemilä, Elizabeth ChalkerPharmacology Research & Perspectives|June 15, 2021
Overall survival in metastatic melanoma correlates with pembrolizumab exposure and T cell exhaustion markersVishal Navani, Moira C Graves, Giovana Celli Marchett, et al.Pharmacology Research & Perspectives|July 5, 2021
Circ_0001821 knockdown suppresses growth, metastasis, and TAX resistance of non-small-cell lung cancer cells by regulating the miR-526b-5p/GRK5 axisYing Liu, Changchao Li, Huiqun Liu, et al.Pharmacology Research & Perspectives|December 29, 2020
Utilization patterns and characteristics of users of biologic anti-inflammatory agents in a large, US commercially insured populationAaron B Mendelsohn, Young Hee Nam, James Marshall, et al.Pharmacology Research & Perspectives|June 15, 2021
Daratumumab provides a survival benefit in relapsed and refractory Multiple Myeloma, independent of baseline clinical characteristics: A meta-analysisCongcong Cao, Xin Zhou, Qun MaPharmacology Research & Perspectives|June 15, 2021
p-cymene impairs SARS-CoV-2 and Influenza A (H1N1) viral replication: In silico predicted interaction with SARS-CoV-2 nucleocapsid protein and H1N1 nucleoproteinAthanasios Panagiotopoulos, Melpomeni Tseliou, Ioannis Karakasiliotis, et al.Pageof 140